Repeated gadoteric acid and gadobutrol exposure causes deterioration of behavior and memory functions in rats: MRI, histopathological and biochemical evidence

[Display omitted] •Gadoteric acid exposure causes hippocampal gliosis and elevates oxidative stress and inflammation in rat brain.•Gadobutrol exposure causes hippocampal gliosis and elevates oxidative stress and inflammation in rat brain.•Gadoteric acid and gadobutrol exposure disrupts memory functi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2021-03, Vol.1754, p.147256-147256, Article 147256
Hauptverfasser: Solmaz, Volkan, Köse Özlece, Hatice, Fatih Bozkurt, Mehmet, Özkul, Bahattin, Erbaş, Oytun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Gadoteric acid exposure causes hippocampal gliosis and elevates oxidative stress and inflammation in rat brain.•Gadobutrol exposure causes hippocampal gliosis and elevates oxidative stress and inflammation in rat brain.•Gadoteric acid and gadobutrol exposure disrupts memory functions as well as behavior in rats.•Neurotoxicity of gadobutrol is relatively lower than gadoteric acid. Gadolinium-based contrast agents (GBCAs) exert effects in different regions of the brain; however, studies on this topic are mostly focused on radiological outcomes of GBCA exposure. This paper is a preliminary attempt to identify whether there are changes in behavioral, cognitive, histopathological, radiological and biochemical characteristics with repeated exposure to gadobutrol and gadoteric acid. The effects of GBCAs were tested with the assessment of 4 groups –each comprised of 6 rats [controls, gadobutrol, gadoteric acid (Doteram), and gadoteric acid (Clariscan)]. Respective treatments of 0.1 ml/kg were administered for 3 weeks, followed by a recovery period of 1 week without any treatment. At the end of this regimen, behavioral tests (open field and passive learning test) were performed. Additionally, histopathological analysis of the hippocampal CA1 and CA3 regions (GFAP measurement and total neuron count), biochemical measurements [TNF-a, Malondialdehyde (MDA), Superoxide dismutase (SOD), homovalinic acid (HVA) and choline acetyl transferase (ChAT) levels], and radiological findings (MRI-region of interest) were carried out in each group. There was a significant impairment in all groups that had received gadolinium in open field and passive avoidance learning tests. Oxidative stress and inflammation markers were significantly elevated in all gadolinium groups. Additionally, increased hippocampal gliosis and decreased MRI-ROIs were observed in rats exposed to gadolinium. Chronic gadoteric acid and gadobutrol exposure causes hippocampal gliosis and elevates oxidative stress and inflammation in rats. Radiological outcomes are also consistent with these findings. Long-term studies might be required to conclude whether gadolinium deposition in the brain causes subtle neurological deficits.
ISSN:0006-8993
1872-6240
DOI:10.1016/j.brainres.2020.147256